Skip to main content
Erschienen in: Heart and Vessels 6/2010

01.11.2010 | Original Article

Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress

verfasst von: Koji Otsuka, Fumio Terasaki, Hiroaki Shimomura, Bin Tsukada, Taiko Horii, Tadashi Isomura, Hisayoshi Suma, Yuro Shibayama, Yasushi Kitaura

Erschienen in: Heart and Vessels | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The ubiquitin (Ub)-proteasome system (UPS) is an important proteolytic mechanism for selecting and digesting cytotoxic proteins. The aim of this study is to elucidate expression and in situ localization of the UPS in the myocardium from patients with dilated cardiomyopathy (DCM) with refractory heart failure. The expression profile of the oxidative stress-induced cytotoxic proteins was also examined. Myocardium was obtained from 26 patients with DCM at the left ventriculoplasty. Ten normal autopsied hearts served as controls. Myocardial expressions of Ub and proteasomes were studied immunohistochemically. Oxidative stresses were examined in point of localization of the oxidation-induced modifier molecules (OMM). The relationship between immunohistochemical results and clinical parameters was also evaluated. Both Ub and proteasomes were stained positive in granular structures accumulating between the myofibrils and adjacent to nuclei in cardiomyocytes. The OMMs were also positive in the same Ub-positive granular structures. The area fraction of Ub, proteasomes and OMM was significantly higher in DCM hearts than in normal controls. Significant positive correlation was observed between the area fractions of Ub and plasma levels of brain natriuretic peptide (p = 0.046) in DCM hearts. In conclusion, enhanced expression of the UPS colocalized with OMM in cardiomyocytes may be involved in the pathophysiology of DCM hearts.
Literatur
1.
Zurück zum Zitat Klausner RD, Sitia R (1990) Protein degradation in the endoplasmic reticulum. Cell 62:611–614CrossRefPubMed Klausner RD, Sitia R (1990) Protein degradation in the endoplasmic reticulum. Cell 62:611–614CrossRefPubMed
2.
Zurück zum Zitat Hershko A, Ciechanover A, Varshavsky A (2000) Basic medical award. The ubiquitin system. Nat Med 6:1073–1081CrossRefPubMed Hershko A, Ciechanover A, Varshavsky A (2000) Basic medical award. The ubiquitin system. Nat Med 6:1073–1081CrossRefPubMed
3.
Zurück zum Zitat Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169–178CrossRefPubMed Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169–178CrossRefPubMed
4.
Zurück zum Zitat Ohsumi Y (2001) Molecular dissection of autophagy: two ubiquitin-like system. Nat Rev Mol Cell Biol 2:211–216CrossRefPubMed Ohsumi Y (2001) Molecular dissection of autophagy: two ubiquitin-like system. Nat Rev Mol Cell Biol 2:211–216CrossRefPubMed
5.
Zurück zum Zitat Wang CW, Klionsky DJ (2003) The molecular mechanism of autophagy. Mol Med 9:65–76PubMed Wang CW, Klionsky DJ (2003) The molecular mechanism of autophagy. Mol Med 9:65–76PubMed
7.
Zurück zum Zitat Bucciantini M, Giannoni E, Chiti F, Broni F, Formiqli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:483–484CrossRef Bucciantini M, Giannoni E, Chiti F, Broni F, Formiqli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:483–484CrossRef
8.
Zurück zum Zitat Belch JJ, Bridges AB, Scott N, Chopra M (1991) Oxygen free radicals and congestive heart failure. Br Heart J 65:245–248CrossRefPubMed Belch JJ, Bridges AB, Scott N, Chopra M (1991) Oxygen free radicals and congestive heart failure. Br Heart J 65:245–248CrossRefPubMed
9.
Zurück zum Zitat Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ (2003) Hyperubiquitination of protein in dilated cardiomyopathy. Proteomics 3:208–216CrossRefPubMed Weekes J, Morrison K, Mullen A, Wait R, Barton P, Dunn MJ (2003) Hyperubiquitination of protein in dilated cardiomyopathy. Proteomics 3:208–216CrossRefPubMed
10.
Zurück zum Zitat Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma T (2001) Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 65:965–968CrossRefPubMed Shimomura H, Terasaki F, Hayashi T, Kitaura Y, Isomura T, Suma T (2001) Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J 65:965–968CrossRefPubMed
11.
Zurück zum Zitat Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883–1898CrossRefPubMed Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883–1898CrossRefPubMed
12.
Zurück zum Zitat Lowe J, Blanchard A, Morrell K, Lennox G, Revnolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 155:9–15CrossRefPubMed Lowe J, Blanchard A, Morrell K, Lennox G, Revnolds L, Billett M, Landon M, Mayer RJ (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 155:9–15CrossRefPubMed
13.
Zurück zum Zitat McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW (2002) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136–2148CrossRefPubMed McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW (2002) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136–2148CrossRefPubMed
14.
Zurück zum Zitat Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524–530CrossRefPubMed Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524–530CrossRefPubMed
15.
Zurück zum Zitat Tran PB, Miller RJ (1999) Aggregates in neurodegenerative disease: crows and power? Trends Neurosci 22:194–197CrossRefPubMed Tran PB, Miller RJ (1999) Aggregates in neurodegenerative disease: crows and power? Trends Neurosci 22:194–197CrossRefPubMed
16.
Zurück zum Zitat McMurray J, Chopra M, Abdullah I, Smith WE, Darqie HJ (1993) Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14:1493–1498PubMed McMurray J, Chopra M, Abdullah I, Smith WE, Darqie HJ (1993) Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J 14:1493–1498PubMed
17.
Zurück zum Zitat Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31:1352–1356CrossRefPubMed Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, Jeejeebhoy KN (1998) Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 31:1352–1356CrossRefPubMed
18.
Zurück zum Zitat Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedqui A (1998) Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97:1536–1539PubMed Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedqui A (1998) Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 97:1536–1539PubMed
19.
Zurück zum Zitat Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K (1999) 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274:23787–23793CrossRefPubMed Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K (1999) 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274:23787–23793CrossRefPubMed
20.
Zurück zum Zitat Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friquet B, Szweda LI (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276:30057–30063CrossRefPubMed Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friquet B, Szweda LI (2001) Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276:30057–30063CrossRefPubMed
21.
Zurück zum Zitat McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW (2002) Impairment of the ubiquitin–proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81:301–306CrossRefPubMed McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW (2002) Impairment of the ubiquitin–proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81:301–306CrossRefPubMed
22.
Zurück zum Zitat Majno G, Joris I (1995) Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 146:3–15PubMed Majno G, Joris I (1995) Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 146:3–15PubMed
23.
Zurück zum Zitat Narula J, Haider N, Virmani R, DiSalvo TG, Kolodqie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189CrossRefPubMed Narula J, Haider N, Virmani R, DiSalvo TG, Kolodqie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189CrossRefPubMed
24.
Zurück zum Zitat Mallat Z, Tedgui A, Fontaliran F, Frank R, Duriqon M, Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190–1196CrossRefPubMed Mallat Z, Tedgui A, Fontaliran F, Frank R, Duriqon M, Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190–1196CrossRefPubMed
25.
Zurück zum Zitat McDonald ER 3rd, El-Deiry WS (2004) Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci USA 101:6170–6175CrossRefPubMed McDonald ER 3rd, El-Deiry WS (2004) Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth. Proc Natl Acad Sci USA 101:6170–6175CrossRefPubMed
26.
Zurück zum Zitat Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJA, Katzeff H (2005) Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38:1093–1101CrossRefPubMed Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJA, Katzeff H (2005) Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38:1093–1101CrossRefPubMed
27.
Zurück zum Zitat Tannous P, Zhu H, Nemchenko A, Berry JM, Johnstone JL, Shelton JM, Miller FJ Jr, Rothermel BA, Hill JA (2008) Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117:3070–3078CrossRefPubMed Tannous P, Zhu H, Nemchenko A, Berry JM, Johnstone JL, Shelton JM, Miller FJ Jr, Rothermel BA, Hill JA (2008) Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 117:3070–3078CrossRefPubMed
28.
Zurück zum Zitat Jung T, Bader N, Grune T (2007) Lipofuscin. Formation, distribution, and metabolic consequences. Ann N Y Acad Sci 1119:97–111CrossRefPubMed Jung T, Bader N, Grune T (2007) Lipofuscin. Formation, distribution, and metabolic consequences. Ann N Y Acad Sci 1119:97–111CrossRefPubMed
29.
Zurück zum Zitat Hasegawa K, Fujiwara H, Doyama K, Mukoyama M, Nakao K, Fujiwara T, Imura H, Kawai C (1993) Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am J Pathol 142:107–116PubMed Hasegawa K, Fujiwara H, Doyama K, Mukoyama M, Nakao K, Fujiwara T, Imura H, Kawai C (1993) Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am J Pathol 142:107–116PubMed
30.
Zurück zum Zitat McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351:9–13CrossRefPubMed McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351:9–13CrossRefPubMed
31.
Zurück zum Zitat Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM (1996) Superiority of brain natriuretic peptide as a hormonal maker of ventricular hypertrophy. Hypertension 28:988–994PubMed Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM (1996) Superiority of brain natriuretic peptide as a hormonal maker of ventricular hypertrophy. Hypertension 28:988–994PubMed
32.
Zurück zum Zitat Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509–516PubMed Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96:509–516PubMed
Metadaten
Titel
Enhanced expression of the ubiquitin-proteasome system in the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an immunohistochemical study with special reference to oxidative stress
verfasst von
Koji Otsuka
Fumio Terasaki
Hiroaki Shimomura
Bin Tsukada
Taiko Horii
Tadashi Isomura
Hisayoshi Suma
Yuro Shibayama
Yasushi Kitaura
Publikationsdatum
01.11.2010
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 6/2010
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-010-0006-3

Weitere Artikel der Ausgabe 6/2010

Heart and Vessels 6/2010 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.